Abstract
The current recommendation for the duration of treatment of patients infected with chronic hepatitis C virus(HCV)genotype 1 is 48 weeks; however, the standard regimen of peginterferon plus ribavirin bears significant adverse effects, which make completion of treatment exceedingly difficult. Reported here are 2 cases ofHIV- HCV-coinfected genotype-1 patients who discontinued treatment early(after 3 and 8 weeks)because of adverse effects yet had a sustained virologic response with undetectable HCV viral loads at follow-up.
| Original language | English |
|---|---|
| Pages (from-to) | 164-168-169 |
| Journal | AIDS Reader |
| Volume | 16 |
| Issue number | 3 |
| State | Published - Mar 2006 |
| Externally published | Yes |
Keywords
- HIV/AIDS
- Hepatitis C
- Hepatitis C Virus genotype 1
- Peginterferon
- Ribavirin
Fingerprint
Dive into the research topics of 'Sustained virologic response with short-course ribavirin and peginterferon treatment in 2 patients coinfected with HIV and HCV genotype 1'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver